CareDx, Inc.
CDNANasdaqCIK 1217234HealthcareFiscal year ends Dec 31
Reports and events: 255 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2023-12-2216:01 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-23-302096 |
| 2023-11-0816:16 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001217234-23-000226 |
| 2023-11-0816:11 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001217234-23-000224 |
| 2023-11-0116:08 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-23-268195 |
| 2023-09-2617:14 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-23-242583 |
| 2023-09-2507:00 ET | 8-K | 8.01 Other events | 0001193125-23-240900 |
| 2023-08-0816:18 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0001217234-23-000180 |
| 2023-08-0816:11 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001217234-23-000178 |
| 2023-06-2014:52 ET | 8-K | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001217234-23-000107 |
| 2023-05-1016:20 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0001217234-23-000096 |
| 2023-05-1016:12 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001217234-23-000094 |
| 2023-04-2816:12 ET | DEF 14A | Proxy statement | 0001217234-23-000078 |
| 2023-04-0307:00 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-23-088888 |
| 2023-03-2816:05 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001193125-23-082138 |
| 2023-03-1317:51 ET | 8-K | 7.01 Regulation FD disclosure | 0001217234-23-000051 |
| 2023-02-2716:28 ET | 10-K | Annual reportPeriod 2022-12-31 | 0001217234-23-000046 |
| 2023-02-2716:11 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001217234-23-000043 |
| 2023-01-0907:03 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-23-004117 |
| 2022-12-0608:01 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-22-298916 |
| 2022-11-2316:02 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-22-292003 |
| 2022-11-0316:26 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001217234-22-000185 |
| 2022-11-0316:23 ET | 10-Q | Quarterly reportPeriod 2022-09-30 | 0001217234-22-000184 |
| 2022-09-0716:06 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-22-239989 |
| 2022-09-0116:06 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-22-236507 |
| 2022-08-0417:20 ET | 10-Q | Quarterly reportPeriod 2022-06-30 | 0001217234-22-000150 |
| 2022-08-0416:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001217234-22-000147 |
| 2022-06-1713:54 ET | 8-K | 5.07 Shareholder vote results | 0001217234-22-000109 |
| 2022-05-2307:30 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-22-156809 |
| 2022-05-0517:13 ET | 10-Q | Quarterly reportPeriod 2022-03-31 | 0001217234-22-000093 |
| 2022-05-0516:07 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001217234-22-000091 |
| 2022-05-0213:15 ET | DEF 14A | Proxy statementPeriod 2022-06-15 | 0001217234-22-000084 |
| 2022-04-1518:29 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-22-105813 |
| 2022-02-2417:07 ET | 10-K | Annual reportPeriod 2021-12-31 | 0001217234-22-000056 |
| 2022-02-2416:07 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001217234-22-000053 |
| 2022-01-1008:38 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001217234-22-000018 |
| 2022-01-0508:27 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001217234-22-000004 |
| 2021-11-1009:06 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001217234-21-000245 |
| 2021-11-0117:29 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-21-315657 |
| 2021-10-2817:21 ET | 10-Q | Quarterly reportPeriod 2021-09-30 | 0001217234-21-000235 |
| 2021-10-2816:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001217234-21-000233 |
| 2021-09-1517:00 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-21-274069 |
| 2021-07-2917:10 ET | 10-Q | Quarterly reportPeriod 2021-06-30 | 0001217234-21-000190 |
| 2021-07-2916:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001217234-21-000188 |
| 2021-07-2016:54 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-21-219712 |
| 2021-07-0116:20 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-21-206325 |
| 2021-06-2118:55 ET | 8-K | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-21-193438 |
| 2021-06-0316:05 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001217234-21-000112 |
| 2021-05-0517:04 ET | 10-Q | Quarterly reportPeriod 2021-03-31 | 0001217234-21-000093 |
| 2021-05-0516:02 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001217234-21-000092 |
| 2021-04-3011:00 ET | DEF 14A | Proxy statementPeriod 2021-06-15 | 0001217234-21-000079 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 13, 2026, 16:18 ET. Listed shows no prices and gives no investment advice.